Keywords: دیپپتیدیل پپتیداز 4; Citrus bioflavonoids; Dipeptidyl peptidase-4; Gliptins; Ultra performance liquid chromatography; Dipeptidyl peptidase-4 inhibitory assay;
مقالات ISI دیپپتیدیل پپتیداز 4 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: دیپپتیدیل پپتیداز 4; DKD; diabetic kidney disease; RAAS; renin-angiotensin-aldosterone system; ESRD; end-stage renal disease; T1DM; type I diabetes mellitus; T2DM; type II diabetes mellitus; CVD; cardiovascular disease; GFR; glomerular filtration rate; AER; albumin excretion
Keywords: دیپپتیدیل پپتیداز 4; T2DM; type 2 diabetes mellitus; PON; paraoxonase; Hmgcr; hepatic 3-hydroxy-3-methylglutaryl-CoA reductase; Scarb1; scavenger receptor class B member 1; Ahr; aryl hydrocarbon receptor; Lipc; hepatic Lipase; Lcat; lecithin-cholesterol acyltransferase; VLDL;
Keywords: دیپپتیدیل پپتیداز 4; Vildagliptin; Drug-induced liver injury; Hypersensitivity; Covalent binding; Nucleophilic trapping agents; ALG; alogliptin; ANG; anagliptin; CRP; C-reactive protein; CYP; cytochrome P450; DILI; drug-induced liver injury; DLST; drug-induced lymphocyte stim
Keywords: دیپپتیدیل پپتیداز 4; Functional foods; Bioactive peptides; Whey proteins; Downstream process; Industrial scale-up; Peptide enrichment techniques; FOSHU; Foods for Specified Health Uses; PDCAAS; protein digestibility corrected amino acid score; BCAAs; branched-chain amino acid
Keywords: دیپپتیدیل پپتیداز 4; ABCA1; ATP-binding cassette transporter; ACOG; American College of Obstetricians and Gynecologists; ACSM; American College of Exercise Medicine; AMPK; AMP-activate protein kinase; ADA; American Diabetes Association; BMI; body mass index; BMR; Basal metabo
Keywords: دیپپتیدیل پپتیداز 4; Albuminuria; Dipeptidyl peptidase-4; Type 1 diabetes mellitus; Diabetic kidney disease; Hypertension; Glycaemic control;
Keywords: دیپپتیدیل پپتیداز 4; GQD; Gegen Qinlian decoction; T2DM; type 2 diabetes; RCTs; randomized clinical trials; AMPK; AMP-activated protein kinase; DPP-4; dipeptidyl peptidase-4; TCM; traditional Chinese medicines; OR; odds ratio; CI; confidence intervals; FPG; fasting plasma glu
Keywords: دیپپتیدیل پپتیداز 4; Arthralgia; Dipeptidyl peptidase-4 inhibitors; Meta-analysis; Systematic review; DPP-4; Dipeptidyl peptidase-4; FDA; Food and Drug Administration; GIP; Glucose-dependent insulinotropic peptide; GLP-1; Glucagon-like peptide-1; IDF; International Diabetes F
Keywords: دیپپتیدیل پپتیداز 4; C-IMT; carotid intima-media thickness test; CV; cardiovascular; DPP4; dipeptidyl peptidase-4; DPP4i; DPP4 inhibitors; GLP1; glucagon-like peptide 1; HbA1c; glycated haemoglobin; HF; heart failure; HR; hazard ratio; MACE; major adverse cardiac event; MI;
Keywords: دیپپتیدیل پپتیداز 4; Diabetes; Glucagon; Islets of Langerhans; Hepatic glucose production; T1D; Type 1 diabetes; T2D; type 2 diabetes; GLP1; glucagon-like peptide 1; DPP4; Dipeptidyl peptidase-4; GR KO mice; glucagon receptor knock out mice; GABA; gamma-aminobutyric acid; PEP
Keywords: دیپپتیدیل پپتیداز 4; Genistein; Morris water maze; Nitric oxide; IL-1β; TNF-α; AChE; acetylcholinesterase; ANCOVA; analysis of co-variance; ChE; cholinesterase; DACD; diabetes associated cognitive decline; DMSO; dimethyl sulfoxide; DNA; deoxyribonucleic acid; DPP-4; dipepti
Keywords: دیپپتیدیل پپتیداز 4; Macrophage; Adipose; Inflammation; Obesity; Fibrosis; Insulin; AMPK; AMP-activated protein kinase; ATM; adipose tissue macrophages; CRP; C-reactive protein; DIO; diet-induced obesity; DPP-4; dipeptidyl peptidase-4; FFA; free fatty acids; GLP-1; glucagon-l
Keywords: دیپپتیدیل پپتیداز 4; AP; action potential; CaMKII; Ca2+/calmodulin-dependent protein kinase II; CaT; Ca2+ transient; dF/dtmax; rate of contraction force rise; dF/dtmin; rate of contraction force fall; dP/dtmax; LV pressure rise; dP/dtmin; LV pressure fall; DPP-4; dipeptidyl p
Keywords: دیپپتیدیل پپتیداز 4; AKI; acute kidney injury; CKD; chronic kidney disease; DPP-4; dipeptidyl peptidase-4; ICD-9-CM; International Classification of Disease, Ninth Revision, Clinical Modification; NHIRD; National Health Insurance Research Database; OR; odds ratios; T2DM; type
Keywords: دیپپتیدیل پپتیداز 4; SGLT2 inhibitor; DPP4 inhibitor; Canagliflozin; Combination treatment; Glucagon-like peptide-1; aGLP-1; active GLP-1; ANOVA; Analysis of variance; AUC; Area under the curve; CMA; (2S)-2-Cyano-1-[trans-4-(morpholinocarbonyl)cyclohexylamino]acetylpyrrolidin
Keywords: دیپپتیدیل پپتیداز 4; CRP; C-reactive protein; HDL; high density lipoprotein; LDL; low density lipoprotein; PPARγ; peroxisome proliferator activated receptor-γ; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon like peptide-1; TRIB3; tribbles homolog 3; ATF-4; activating transc
Keywords: دیپپتیدیل پپتیداز 4; GLUT; Glucose transporter; T1DM; Type-1 diabetes mellitus; T2DM; Type-2 diabetes mellitus; PKB/Akt; protein kinase B; GSK-3; glycogen synthase kinase-3; PGC-1α; peroxisome proliferator-activated receptor gamma coactivator-1α; FOXO; forkhead box O; VLDL;
Keywords: دیپپتیدیل پپتیداز 4; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Thiazolinediones; Pioglitazone; Dipeptidyl peptidase 4 (DPP-4) inhibitors; Glucagon-like peptide-1 receptor agonists (GLP-1RA); BCAAs; branched-chain amino acids; ARB; angioten
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase-4; Insulin resistance; Type 1 diabetes; Adipokines; Renal function;
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase-4; Type 1 diabetes; Alanine aminotranfrerase
Keywords: دیپپتیدیل پپتیداز 4; Glycated albumin; Glycosylated hemoglobin; Glucose lowering medication; Taiwan; Reference range; Atherosclerosis; Prevention; ALT; Alanine aminotransferase; XGI; Alpha-Glucosidase Inhibitor; BG; Biguanides; CRE; Creatinine; DM; Diabetes Mellitus; DPP-4; D
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase-4; Saxagliptin; Parkinson disease; Dopamine; Rotenone; cAMP; BDNF; Apoptosis; Free radical; 6-OHD; 6-hydroxydopamine; AD; Alzheimer's disease; ADP; adenosine diphosphate; ATP; adenosine triphosphate; Bcl-2; B-cell lymphoma-2; BDNF; br
Keywords: دیپپتیدیل پپتیداز 4; GLP-1; glucagon-like peptide 1; 25OHD; 25-hydroxyvitamin D; RDA; recommended daily allowance; IGF-1; insulin-like growth factor 1; HDL; high density lipoprotein; HOMA-IR; homeostatic model assessment of insulin resistance; HbA1c; glycated hemoglobin; HFD;
Keywords: دیپپتیدیل پپتیداز 4; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; DPP-4; dipeptidyl peptidase-4; BMI; body mass index; CNS; central nervous system; EMA; European Medicines Agency; FDA; US Food and Drug Administration; (Pro3)GIP; proline-3
Keywords: دیپپتیدیل پپتیداز 4; ModEx; moderate-intensity aerobic continuous exercise; IntEx; high-intensity aerobic interval exercise; BMI; body mass index; NoEX; no exercise; VO2max; maximal oxygen uptake; GLP-1; glucagon-like peptide-1; GIP; glucose-dependent insulinotropic polypepti
Keywords: دیپپتیدیل پپتیداز 4; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; SD; Sprague-Dawley; NF-κB; nuclear factor-κB; GIP; gastric inhibitory polypeptide; ICAM-1; intercellular adhesion molecule-1; PAM; periodic acid-methenamine silver; cAMP; cyclic AMP; CRP;
Keywords: دیپپتیدیل پپتیداز 4; Glycated hemoglobin (HbA1c); Body weight; Postprandial plasma glucose (PPG); AE; adverse event; BMI; body mass index; DPP-4; dipeptidyl peptidase-4; FPG; fasting plasma glucose; GI; gastrointestinal; GLP-1; glucagon-like peptide-1; HbA1c; glycated hemoglo
Keywords: دیپپتیدیل پپتیداز 4; Intestine; Lipoprotein; Chylomicron; GLP-1; GLP-2; Resveratrol; Apo; apolipoprotein; CVD; cardiovascular diseases; DPP-4; dipeptidyl peptidase-4; FFA; free fatty acids; GIP; gastric inhibitory polypeptide; GLP-1; glucagon-like peptide-1; GLP-2; glucagon-l
Keywords: دیپپتیدیل پپتیداز 4; AGE; advanced glycation end product; aBMD; areal bone mineral density; BMD; bone mineral density; BMI; body mass index; DPP-4; dipeptidyl peptidase-4; DXA; dual-energy X-ray absorptiometry; eBMD; estimated bone mineral density; GLP-1; glucagon-like peptid
Keywords: دیپپتیدیل پپتیداز 4; AAV1; adeno-associated virus serotype 1; ACC; American College of Cardiology; ACCELERATE; A Study of Evacetrapib in High-Risk Vascular Disease; ACCORD; Action to Control Cardiovascular Risk in Diabetes; ADA; American Diabetes Association; AMP; adenosine m
Keywords: دیپپتیدیل پپتیداز 4; T2DM; type 2 diabetes mellitus; MI; myocardial infarction; CAD; coronary artery disease; I R injury; ischemia reperfusion injury; LV; left ventricle; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; PPARs; peroxisome proliferators-activated
Keywords: دیپپتیدیل پپتیداز 4; DPP-4; dipeptidyl peptidase-4; GLP-1; glucagon-like peptide-1; IRS-2; insulin receptor substrate-2; CREB; cAMP response element-binding protein; Gck; glucokinase; GIR; glucose infusion rate(s); EGP; endogenous glucose production; Rd; rate of glucose disap
Evaluation of the association of single nucleotide polymorphisms in DDP4 and CDK5RAP2 genes with rheumatoid arthritis susceptibility in Iranian population
Keywords: دیپپتیدیل پپتیداز 4; RA; rheumatoid arthritis; SNP; single nucleotide polymorphism; GWAS; genome-wide association study; HLA; human leukocyte antigen; DPP4; dipeptidyl peptidase-4; CD26; cluster of differentiation 26; CDK-5; Cyclin-dependent kinase 5; CDK5RAP2; Cyclin-depende
Malondialdehyde-modified LDL-related variables are associated with diabetic kidney disease in type 2 diabetes
Keywords: دیپپتیدیل پپتیداز 4; Malondialdehyde-modified low-density lipoprotein; Type 2 diabetes; Albuminuria; Estimated glomerular filtration rate; Dyslipidemia; AER; albumin excretion rate: BMI, body mass index; CKD; chronic kidney disease; CVD; cardiovascular disease; DPP-4; dipepti
Peptide degradation and the role of DPP-4 inhibitors in the treatment of type 2 diabetes
Keywords: دیپپتیدیل پپتیداز 4; DPP-4; dipeptidyl peptidase-4; GIP; glucose-dependent insulinotropic polypeptide; GLP-1; glucagon-like peptide-1; GRP; gastrin-releasing peptide; NEP; neutral endopeptidase; OXM; oxyntomodulin; PACAP; pituitary adenylate cyclase-activating polypeptide; PY
A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagy
Keywords: دیپپتیدیل پپتیداز 4; Akt; protein kinase B; Ambra1; Autophagy And Beclin 1 Regulator 1; AMPK; 5â² AMP-activated protein kinase; Atg; autophagy related proteins; CAMKK; Ca2+/calmodulin-dependent protein kinase kinase; DFCP1; double FYVE-containing protein 1; DPP4; dipeptidyl
Design, synthesis, and evaluation of novel l-phenylglycine derivatives as potential PPARγ lead compounds
Keywords: دیپپتیدیل پپتیداز 4; Diabetes mellitus; l-Phenylglycine; Tyrosine derivatives; Thiazolidinediones; Peroxisome proliferator-activated receptor; Dipeptidyl peptidase-4; α-Glucosidase;
Monoclonal antibodies against interleukin 13 and interleukin 31RA in development for atopic dermatitis
Keywords: دیپپتیدیل پپتیداز 4; atopic dermatitis; dipeptidyl peptidase-4; Eczema Area and Severity Index; interleukin; IL-31RA; Investigator's Global Assessment; Janus kinase; c-Jun N-terminal kinase; mitogen-activated protein kinase; oncostatin M receptor β; STAT signal transducer a
Investigation of in vitro genotoxic effects of an anti-diabetic drug sitagliptin
Keywords: دیپپتیدیل پپتیداز 4; Sitagliptin; Antidiabetic drug; Human lymphocytes; Genotoxicity; T2DM; Type 2 diabetes mellitus; DPP-4; dipeptidyl peptidase-4; GLP-1; incretin hormones glucagon-like peptide-1; GIP; glucose-dependent insulinotropic polypeptide; CAs; chromosome aberration
Pomegranate polyphenols and urolithin A inhibit α-glucosidase, dipeptidyl peptidase-4, lipase, triglyceride accumulation and adipogenesis related genes in 3T3-L1 adipocyte-like cells
Keywords: دیپپتیدیل پپتیداز 4; α-GLU; α-glucosidase; DPP-4; dipeptidyl peptidase-4; PPARγ; peroxisome proliferator-activated receptor gamma; GLUT4; glucose transporter type 4; FABP4; fatty acid binding protein 4; Ellagic acid (CAS: 476-66-4); Punicalagin (CAS: 65995-63-3); Urolithin
Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China
Keywords: دیپپتیدیل پپتیداز 4; BMI; body mass index; BDNF; brain-derived neurotrophic factor; CRP; C-reactive protein; CREB; cAMP response element binding protein; DPP4; dipeptidyl peptidase-4; DBR; DPP4 activity to BDNF ratio; IL-6; interleukin 6; MCI; mild cognitive impairment; MoCA;
Brief CommunicationDipeptidyl peptidase-4 inhibitor treatment induces a greater increase in plasma levels of bioactive GIP than GLP-1 in non-diabetic subjects
Keywords: دیپپتیدیل پپتیداز 4; Receptor-mediated incretin bioassays; Glucose-dependent insulinotropic polypeptide; Glucagon-like peptide-1; Dipeptidyl peptidase-4;
Searching for animal models and potential target species for emerging pathogens: Experience gained from Middle East respiratory syndrome (MERS) coronavirus
Keywords: دیپپتیدیل پپتیداز 4; Animal model; Coronavirus (CoV); Emerging pathogen; Middle East respiratory syndrome (MERS); Reservoir; BSL; biosafety level; DPP4; dipeptidyl peptidase-4; FDA; Food and Drug Administration; HCoV; human coronaviruses; hDPP4; human dipeptidyl peptidase-4;
The effects of DPP-4 inhibitor on hypoxia-induced apoptosis in human umbilical vein endothelial cells
Keywords: دیپپتیدیل پپتیداز 4; Endothelial cell; Dipeptidyl peptidase-4; Apoptosis; Hypoxia;
Everlasting flower (Helichrysum stoechas Moench) as a potential source of bioactive molecules with antiproliferative, antioxidant, antidiabetic and neuroprotective properties
Keywords: دیپپتیدیل پپتیداز 4; HSME; Helichrysum stoechas methanolic extract; DPPH; 2,2-diphenyl-1-picrylhydrazyl; O2â; superoxide radical; XO; xanthine oxidase; AChE; acetylcholinesterase; MAO-A; monoamine oxidase A; TYR; tyrosinase; α-GLU; glucosidase; DPP-4; dipeptidyl peptidase-
Increased dipeptidyl peptidase-4 accelerates diet-related vascular aging and atherosclerosis in ApoE-deficient mice under chronic stress
Keywords: دیپپتیدیل پپتیداز 4; Chronic stress; Vascular senescence; Atherosclerosis; Inflammation; Dipeptidyl peptidase-4;
DPP-4 inhibition protects human umbilical vein endothelial cells from hypoxia-induced vascular barrier impairment
Keywords: دیپپتیدیل پپتیداز 4; Dipeptidyl peptidase-4; Hypoxia; Endothelial cell; Adherens junctions; NF-κB;
Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay
Keywords: دیپپتیدیل پپتیداز 4; BGG; bovine gamma globulin; BMI; body mass index; CI; confidence interval; CLSI; Clinical Laboratory Standards Institute; CV; coefficient of variation; DPP-4; dipeptidyl peptidase-4; HAMA; human anti-mouse antibodies; Ig; immunoglobulin; IL-13; interleuki
GIP(3-30)NH2 is a potent competitive antagonist of the GIP receptor and effectively inhibits GIP-mediated insulin, glucagon, and somatostatin release
Keywords: دیپپتیدیل پپتیداز 4; BSA; bovine serum albumin; DPP-4; dipeptidyl peptidase-4; GIP; glucose-dependent insulinotropic polypeptide; GIPR; glucose-dependent insulinotropic polypeptide receptor; GLP-1; glucagon-like peptide-1; HBS; HEPES-buffered saline; Glucose-dependent insulin